The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Proteomic evaluation of HER-2 expression and activation in tumors that are RNA overexpressed, but not DNA amplified.
 
Timothy Cannon
Honoraria - AstraZeneca; Bayer; Sirflex; Sirflex
Consulting or Advisory Role - Intermountain Healthcare
 
Laura Johnston
No Relationships to Disclose
 
Emanuel Petricoin
Leadership - Ceres Nanosciences; Perthera
Stock and Other Ownership Interests - Ceres Nanosciences; Perthera
Consulting or Advisory Role - Ceres Nanosciences; DAiNA, Inc.; Ignite Proteomics, Inc.; Perthera; Targeted Biosciences, Inc.
Research Funding - Ceres Nanosciences (Inst); Deciphera; G1 Therapeutics (Inst); Genentech (Inst); Mirati Therapeutics (Inst); SpringWorks Therapeutics
Patents, Royalties, Other Intellectual Property - NIH Patents Licensing Fee Distribution/Royalty; University assigned patent licensing fee/royalty
Travel, Accommodations, Expenses - Ceres Nanosciences; Perthera
 
Jamie Randall
No Relationships to Disclose
 
Whitney Swain
No Relationships to Disclose
 
Thomas Conrads
Employment - INOVA Health System
Consulting or Advisory Role - Thermo Fisher Scientific
 
Allison Hunt
No Relationships to Disclose